Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 64 | 1 | 63 | 0 |
| Shares | 14.4M | 1.19M | 14.9M | +1.76M (+13.3%) |
| Value | $87.7M | $7.25M | $74.6M | −$5.84M (−7.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,229,477 | $6.15M | 0.00% |
| Advantage Alpha Capital Partners LP | 52,876 | $264.3K | 0.06% |
| American Alpha Advisors, LLC | 10,000 | $50.0K | 0.05% |
| Cornerstone Planning Group LLC | 88 | $422 | 0.00% |
| Sterling Capital Management LLC | 62 | $310 | 0.00% |
| Massmutual Trust Co FSB | 58 | $290 | 0.00% |
| Capital Performance Advisors LLP | 5 | $25 | 0.00% |
| Simplex Trading, LLC | 21 | $0 | 0.00% |
Sold out (8)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Hillsdale Investment Management Inc. | 24,491 | $149.6K |
| Squarepoint Ops LLC | 17,702 | $108.2K |
| Pinnacle Wealth Planning Services, Inc. | 12,289 | $75.1K |
| Manufacturers Life Insurance Company, The | 11,310 | $69.1K |
| Acadian Asset Management LLC | 8,086 | $49.0K |
| MetLife Investment Management | 4,526 | $27.7K |
| The PNC Financial Services Group, Inc. | 112 | $684 |
| Covestor Ltd | 77 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,187,242 | $7.25M |